IO Biotech Inc
NASDAQ:IOBT
IO Biotech Inc
Operating Expenses
IO Biotech Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IO Biotech Inc
NASDAQ:IOBT
|
Operating Expenses
-$91.4m
|
CAGR 3-Years
-108%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Operating Expenses
-kr11.7B
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-34%
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Operating Expenses
-kr884.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-16%
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Operating Expenses
-€642.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Operating Expenses
-kr3B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-16%
|
Bioporto A/S
CSE:BIOPOR
|
Operating Expenses
-kr80m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-11%
|
See Also
What is IO Biotech Inc's Operating Expenses?
Operating Expenses
-91.4m
USD
Based on the financial report for Dec 31, 2023, IO Biotech Inc's Operating Expenses amounts to -91.4m USD.
What is IO Biotech Inc's Operating Expenses growth rate?
Operating Expenses CAGR 3Y
-108%
Over the last year, the Operating Expenses growth was -28%. The average annual Operating Expenses growth rates for IO Biotech Inc have been -108% over the past three years .